These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23508615)

  • 1. Nonalcoholic fatty liver disease and severity of cardiovascular disease manifestations.
    Athyros VG; Katsiki N; Karagiannis A
    Angiology; 2013 Nov; 64(8):572-5. PubMed ID: 23508615
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease and atherosclerosis.
    Targher G
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):e117; author reply e117-8. PubMed ID: 15980265
    [No Abstract]   [Full Text] [Related]  

  • 3. Associations between liver histology and early carotid atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Targher G
    Hepatology; 2005 Oct; 42(4):974-5; discussion 975. PubMed ID: 16175589
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
    Schindhelm RK; Heine RJ; Diamant M
    Diabetes Care; 2007 Sep; 30(9):e94; author reply e95. PubMed ID: 17726184
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonalcoholic Fatty Liver Disease, Cardiovascular Risk, and Carotid Inflammation.
    Al-Rasadi K; Rizzo M; Montalto G; Berg G
    Angiology; 2015 Aug; 66(7):601-3. PubMed ID: 25381142
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?
    Domanski JP; Park SJ; Harrison SA
    J Clin Gastroenterol; 2012; 46(5):427-30. PubMed ID: 22469639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of unknown peripheral arterial disease in patients with coronary artery disease: data in primary care from the IPSILON study.
    Kownator S; Cambou JP; Cacoub P; Léger P; Luizy F; Herrmann MA; Priollet P
    Arch Cardiovasc Dis; 2009; 102(8-9):625-31. PubMed ID: 19786266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease.
    Church TS; Kuk JL; Ross R; Priest EL; Biltoft E; Blair SN
    Gastroenterology; 2006 Jun; 130(7):2023-30. PubMed ID: 16762625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
    Targher G; Bertolini L; Padovani R; Rodella S; Tessari R; Zenari L; Day C; Arcaro G
    Diabetes Care; 2007 May; 30(5):1212-8. PubMed ID: 17277038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspective: nonalcoholic fatty liver disease and cardiovascular risk.
    Nestel PJ; Mensink RP
    Curr Opin Lipidol; 2013 Feb; 24(1):1-3. PubMed ID: 23298957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The association of cardiovascular risk factors with nonalcoholic fatty liver disease in health checkup examinees].
    Yu JH; Lee KS; Lee SY; Hong AR; Park YS
    J Prev Med Public Health; 2008 Nov; 41(6):407-12. PubMed ID: 19037170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty liver and the metabolic syndrome.
    Neuschwander-Tetri BA
    Curr Opin Gastroenterol; 2007 Mar; 23(2):193-8. PubMed ID: 17268250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease in severely obese adolescent and adult patients.
    Holterman AX; Guzman G; Fantuzzi G; Wang H; Aigner K; Browne A; Holterman M
    Obesity (Silver Spring); 2013 Mar; 21(3):591-7. PubMed ID: 23592668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relation between peripheral arterial occlusive disease and cardiovascular diseases in elderly population: a cross-section study in Wanshoulu area, Beijing].
    Li XY; Wang J; He Y; Fan L
    Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(21):1847-51. PubMed ID: 14642063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease and vascular risk.
    Bhatia LS; Curzen NP; Byrne CD
    Curr Opin Cardiol; 2012 Jul; 27(4):420-8. PubMed ID: 22596186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High sensitivity C-reactive protein in cardiovascular risk assessment. CRP mania or useful screening?
    Sellmayer A; Limmert T; Hoffmann U
    Int Angiol; 2003 Mar; 22(1):15-23. PubMed ID: 12771851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk.
    Ramos R; Quesada M; Solanas P; Subirana I; Sala J; Vila J; Masiá R; Cerezo C; Elosua R; Grau M; Cordón F; Juvinyà D; Fitó M; Isabel Covas M; Clarà A; Angel Muñoz M; Marrugat J;
    Eur J Vasc Endovasc Surg; 2009 Sep; 38(3):305-11. PubMed ID: 19515589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.
    Loria P; Lonardo A; Bellentani S; Day CP; Marchesini G; Carulli N
    Nutr Metab Cardiovasc Dis; 2007 Nov; 17(9):684-98. PubMed ID: 17560098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of cardiovascular risk factors and concentration of C-reactive protein in Type D personality persons without cardiovascular disease.
    Einvik G; Dammen T; Hrubos-Strøm H; Namtvedt SK; Randby A; Kristiansen HA; Somers VK; Nordhus IH; Omland T
    Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):504-9. PubMed ID: 21450648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.